title: Biomarkers, mineralocorticoid receptor antagonism, and cardiorenal remodeling.
authors.affiliation: Duke University Medical Center, Durham, North Carolina. Electronic address: mona.fiuzat@duke.edu.
authors.forename: Mona
authors.initials: M
authors.lastname: Fiuzat
authors.affiliation: Mayo Clinic, Rochester, Minnesota.
authors.forename: John C
authors.initials: JC
authors.lastname: Burnett
mesh_terms: D058186:Acute Kidney Injury / Q000188:drug therapy*; D000818:Animals; D037502:Galectin 3 / Q000037:antagonists & inhibitors* / Q000494:pharmacology*; D006333:Heart Failure / Q000188:drug therapy*; D007378:Interleukins / Q000235:genetics*; D008297:Male; D009203:Myocardial Infarction / Q000188:drug therapy*; D017472:Receptors, Interleukin-1 / Q000235:genetics*; D013148:Spironolactone / Q000627:therapeutic use*; D015854:Up-Regulation / Q000187:drug effects*; D018487:Ventricular Dysfunction, Left / Q000188:drug therapy*; D020257:Ventricular Remodeling
chemical_list: D037502:Galectin 3; D007378:Interleukins; D017472:Receptors, Interleukin-1; D013148:Spironolactone
keywords: biomarkers; mineralicorticoid receptor antagonist; remodeling